Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
OPERATING ACTIVITIES:
Net income	$ 4,617	$ 2,124
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation	3,483	3,983
Stock-based compensation expense	2,472	1,551
Change in provision for losses on accounts receivable	(149)	220
(Gain) on disposal of assets		(1,887)
Changes in operating assets and liabilities:
Trade receivables	4,748	11,242
Inventories	27,901	7,007
Other current assets	(2,622)	2,539
Other assets		(518)
Accounts payable - trade	(6,311)	(28,556)
Accrued liabilities	(3,430)	(959)
Other long-term liabilities	(247)	(655)
Net cash provided by (used in) operating activities	30,462	(3,909)
INVESTING ACTIVITIES:
Proceeds from the sale of capital assets		1,937
Capital expenditures	(3,597)	(2,867)
Net cash (used in) investing activities	(3,597)	(930)
FINANCING ACTIVITIES:
Dividends paid	(3,241)	(3,060)
Treasury stock purchases	(2,968)	(27,958)
Proceeds from lines of credit	254,482	148,589
Payments on lines of credit	(274,494)	(110,496)
Proceeds from issuance of common stock		118
Shares withheld for tax payments on vested restricted shares	(419)	(293)
Net cash (used in) provided by financing activities	(26,640)	6,900
Increase in cash and cash equivalents	225	2,061
Cash and cash equivalents at beginning of the period	2,184	1,342
Cash and cash equivalents at end of the period	2,409	3,403
SUPPLEMENTAL INFORMATION
Cash paid for amounts included in lease liabilities	6,575	4,515
Right-of-use assets exchanged for lease liabilities	35,305	16,814
Interest paid	1,079	546
Income taxes, net	2,911	(1,278)
Capital expenditures in accounts payable	$ 140	$ 56